PapersPMID:41189159
Effects of Ginkgo diterpene lactone gluconate injection combined with vascular recanalization on patients with large-vessel occlusive cerebral infarction: A clinical observation study.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 7 days
- Dose studied, every finding
- 5 mL (25 mg ginkgo diterpene lactone) intravenously once daily for 7 days, started within 2 hours after thrombectomy
- Population, every finding
- Adults with acute large-vessel occlusive cerebral infarction after endovascular recanalisation; all patients also received butylphthalide, statins and standard antithrombotic care; secondary endpoint
No finding here moved its endpoint.
What did not
How to read these marks →“There was no statistically significant difference between the 2 groups in the incidence of malignant brain edema, symptomatic intracerebral hemorrhage, and mortality (P values:.288,.644,.390, respectively).”
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Patients with acute large-vessel occlusive cerebral infarction after revascularization (TIMI flow 2b or 3), Ma'anshan People's Hospital; subject is ginkgo diterpene lactone meglumine injection, not a whole ginkgo leaf extract
- Participants
- 80
- Comparator
- no treatment
- Duration
- 7 days
- Endpoints measured
- 19